28.8 C
New York
Sunday, June 14, 2026

Tag: vaccine

newssourceFORcompanyinformationcontent1marketreleases

Europe Single-use Bioreactors Market to Reach $3.34 Billion by 2032, Growing at a CAGR of 15.3% from 2025, Says Meticulous Research®

Market Growth Driven by Rapid Disposable Technology Adoption, Expanding Biopharmaceutical Sector, and Government Support for Bioproduction REDDING, Calif., June 30, 2025 /PRNewswire/ --According to a...

Piramal Pharma Solutions Breaks Ground on $90M Expansion Plan

Piramal Pharma Solutions is investing $90M to expand two of its U.S. facilities, adding commercial-scale manufacturing capabilities and significantly enhancing the capacity and efficiency...

Piramal Pharma Solutions Breaks Ground on $90M Expansion Plan

Piramal Pharma Solutions is investing $90M to expand two of its U.S. facilities, adding commercial-scale manufacturing capabilities and significantly enhancing the capacity and efficiency...

Piramal Pharma Solutions Breaks Ground on $90M Expansion Plan

Piramal Pharma Solutions is investing $90M to expand two of its U.S. facilities, adding commercial-scale manufacturing capabilities and significantly enhancing the capacity and efficiency...

Industrial Chillers Market to Reach USD 16.5 Billion by 2032 – Meticulous Research®

Water-Cooled Systems Drive 4.4% CAGR Growth as Process Cooling Demand Surges Across Chemical, Pharmaceutical, and Manufacturing Industries Worldwide REDDING, Calif., June 27, 2025 /PRNewswire/ ---...

Industrial Chillers Market to Reach USD 16.5 Billion by 2032 – Meticulous Research®

Water-Cooled Systems Drive 4.4% CAGR Growth as Process Cooling Demand Surges Across Chemical, Pharmaceutical, and Manufacturing Industries Worldwide REDDING, Calif., June 27, 2025 /PRNewswire/ ---...

Freeze Drying Equipment Market to Surge from USD 4.9 Billion to USD 8.4 Billion by 2032 – Meticulous Research®

Lyophilization Process Innovation, Food Preservation Demand, and Pharmaceutical Industry Expansion Drive 7.9% CAGR Growth Across Global Markets REDDING, Calif., June 27, 2025 /PRNewswire/ -- The...

Freeze Drying Equipment Market to Surge from USD 4.9 Billion to USD 8.4 Billion by 2032 – Meticulous Research®

Lyophilization Process Innovation, Food Preservation Demand, and Pharmaceutical Industry Expansion Drive 7.9% CAGR Growth Across Global Markets REDDING, Calif., June 27, 2025 /PRNewswire/ -- The...

GC Biopharma USA Highlights Innovative Manufacturing Approach to IVIG Safety at 2025 CIS Annual Meeting

Differences in manufacturing processes impact the tolerability of intravenous immune globulin (IVIG) products GC Biopharma's manufacturing process reduces FXIa to undetectable levels – a critical...

EVA Pharma and BioPharma Town – Qiantang District, Hangzhou Sign a Strategic Cooperation Agreement

EVA Pharma Deepens Its Roots in China’s Thriving Biopharmaceutical Ecosystem with The Inauguration of Its Hangzhou Office 
EVA Pharma Deepens Its Roots in China’s Thriving Biopharmaceutical Ecosystem with The Inauguration of Its Hangzhou Office

Bavarian Nordic Announces the Initiation of Clinical Trials of Mpox Vaccine in Infants and Pregnant Women

COPENHAGEN, Denmark, June 26, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today the initiation of the first of two clinical trials designed to support approval and use of the MVA-BN® mpox/smallpox vaccine in vulnerable populations: infants under 2 years of age and pregnant and breastfeeding women

Appili Therapeutics Reports Fiscal Year 2025 Financial and Operational Results

LIKMEZ™ (ATI-1501) for Metronidazole Oral Suspension 500mg/5mL re-launched and commercial sales ongoing  

Grand Challenges Canada to Anchor Gavi’s Innovation Fund to Scale Immunization Solutions

New strategic partnership will accelerate the scale-up of high-impact immunization delivery innovations BRUSSELS, June 25, 2025 /CNW/ - Grand Challenges Canada (GCC), one of the world's...

Serina Therapeutics to Present at FORCE Family Office Investor Webinar on June 26, 2025

HUNTSVILLE, AL, June 23, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology, is pleased to announce that Chief Executive Officer Steve Ledger will present at an upcoming FORCE Family Office investor webinar titled "New Drug Optimization Platform to Transform Parkinson’s Care.” The Event is scheduled to take place on Thursday, June 26, 2025, at 12:00 p.m. ET / 9:00 a.m. PT.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsVaccine

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers